Compare AGEN & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGEN | KGEI |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.4M | 139.3M |
| IPO Year | 1999 | 2009 |
| Metric | AGEN | KGEI |
|---|---|---|
| Price | $3.47 | $5.88 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 889.8K | 220.5K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 1.02 | N/A |
| Revenue | ★ $42,877,086.00 | N/A |
| Revenue This Year | $107.63 | $32.37 |
| Revenue Next Year | N/A | $4.72 |
| P/E Ratio | ★ $3.48 | $7.94 |
| Revenue Growth | ★ 89.95 | N/A |
| 52 Week Low | $2.71 | $3.35 |
| 52 Week High | $7.34 | $8.27 |
| Indicator | AGEN | KGEI |
|---|---|---|
| Relative Strength Index (RSI) | 42.93 | 61.75 |
| Support Level | $2.91 | $5.13 |
| Resistance Level | $4.72 | $6.23 |
| Average True Range (ATR) | 0.25 | 0.26 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 24.30 | 97.75 |
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.